Skip to main content

CoronaVac Study

Submitted by rileyta on July 14, 2021 - 10:09 AM

CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, during trials in Turkey was found to have a good safety profile and to be well tolerated among individuals 18 years and older. Read more about this study by clicking the blue box.

Content Source:

The Lancet

Content Author: